Literature DB >> 32932345

Delivering Care From an Unstable Evidence Base: The Evolving Care of Coronavirus Disease 2019 Through the Lens of High-Flow Nasal Oxygen.

Sara C Auld1, Mark Caridi-Scheible2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32932345      PMCID： PMC7814663          DOI： 10.1097/CCM.0000000000004626

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   9.296


× No keyword cloud information.
  15 in total

1.  Failure of high-flow nasal cannula therapy may delay intubation and increase mortality.

Authors:  Byung Ju Kang; Younsuck Koh; Chae-Man Lim; Jin Won Huh; Seunghee Baek; Myongja Han; Hyun-Suk Seo; Hee Jung Suh; Ga Jin Seo; Eun Young Kim; Sang-Bum Hong
Journal:  Intensive Care Med       Date:  2015-02-18       Impact factor: 17.440

2.  Which Multicenter Randomized Controlled Trials in Critical Care Medicine Have Shown Reduced Mortality? A Systematic Review.

Authors:  Carlos A Santacruz; Adriano J Pereira; Edgar Celis; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2019-12       Impact factor: 7.598

3.  Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.

Authors:  Giacomo Grasselli; Alberto Zangrillo; Alberto Zanella; Massimo Antonelli; Luca Cabrini; Antonio Castelli; Danilo Cereda; Antonio Coluccello; Giuseppe Foti; Roberto Fumagalli; Giorgio Iotti; Nicola Latronico; Luca Lorini; Stefano Merler; Giuseppe Natalini; Alessandra Piatti; Marco Vito Ranieri; Anna Mara Scandroglio; Enrico Storti; Maurizio Cecconi; Antonio Pesenti
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

4.  Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks.

Authors:  David S Hui; Benny K Chow; Thomas Lo; Owen T Y Tsang; Fanny W Ko; Susanna S Ng; Tony Gin; Matthew T V Chan
Journal:  Eur Respir J       Date:  2019-04-11       Impact factor: 16.671

5.  Early awake prone position combined with high-flow nasal oxygen therapy in severe COVID-19: a case series.

Authors:  Qiancheng Xu; Tao Wang; Xuemei Qin; Yanli Jie; Lei Zha; Weihua Lu
Journal:  Crit Care       Date:  2020-05-24       Impact factor: 9.097

6.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.

Authors:  Xiaobo Yang; Yuan Yu; Jiqian Xu; Huaqing Shu; Jia'an Xia; Hong Liu; Yongran Wu; Lu Zhang; Zhui Yu; Minghao Fang; Ting Yu; Yaxin Wang; Shangwen Pan; Xiaojing Zou; Shiying Yuan; You Shang
Journal:  Lancet Respir Med       Date:  2020-02-24       Impact factor: 30.700

7.  Patient self-proning with high-flow nasal cannula improves oxygenation in COVID-19 pneumonia.

Authors:  Marat Slessarev; Jason Cheng; Michaela Ondrejicka; Robert Arntfield
Journal:  Can J Anaesth       Date:  2020-04-21       Impact factor: 5.063

8.  ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019.

Authors:  Sara C Auld; Mark Caridi-Scheible; James M Blum; Chad Robichaux; Colleen Kraft; Jesse T Jacob; Craig S Jabaley; David Carpenter; Roberta Kaplow; Alfonso C Hernandez-Romieu; Max W Adelman; Greg S Martin; Craig M Coopersmith; David J Murphy
Journal:  Crit Care Med       Date:  2020-09       Impact factor: 9.296

9.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

10.  High-Flow Nasal Oxygen in Coronavirus Disease 2019 Patients With Acute Hypoxemic Respiratory Failure: A Multicenter, Retrospective Cohort Study.

Authors:  Jingen Xia; Yi Zhang; Lan Ni; Lei Chen; Changzhi Zhou; Chang Gao; Xiaojing Wu; Jun Duan; Jungang Xie; Qiang Guo; Jianping Zhao; Yi Hu; Zhenshun Cheng; Qingyuan Zhan
Journal:  Crit Care Med       Date:  2020-11       Impact factor: 9.296
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.